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Abstract
Background: Plaque morphology directly correlates with risk of embolism and the recently developed dual-source
computed tomography angiography (DSCTA) may help to detect plaques more precisely. The aim of our study
was to evaluate the prevalence and morphology of carotid and cerebrovascular atherosclerotic plaques in patients
with symptomatic type 2 diabetes mellitus (DM) by DSCTA.
Methods: From July 2009 to August 2010, DSCTA was prospectively performed in 125 consecutive patients with
symptomatic type 2 DM. We retrospectively analyzed plaque type, distribution, and extensive and obstructive
natures were determined for each segment for all patients.
Results: Atherosclerotic plaques were detected in 114 (91.2%) patients. Relatively more noncalcified (45%) and
calcified (39%) plaques and less mixed (16%) plaques were observed (p < 0.001). Noncalcified plaques were found
mainly in the intracranial arteries (81.8%), mixed plaques in the intracranial arteries (25.2%) and intracranial internal
carotid artery (ICA) (56.1%). Calcified plaques were found mainly in the intracranial ICA (65.9%) and extracranial
arteries (28.2%) (for all, p < 0.001). Extension of plaques from the 1st to 5th segments was observed in 67 (58.8%)
patients and from the 6th to 10th segments in 35 (30.7%) patients. The most common site of all detected plaques
was the cavernous segment. Regarding stenosis, there were significantly more nonobstructive than obstructive
stenosis (91% vs. 9%, p < 0.001).
Conclusion: DSCTA detected a high prevalence of plaques in patients with symptomatic type 2 DM. A relatively
high proportion of plaques were noncalcified, as well as with nonobstructive stenosis. The distribution of plaques
was extensive, with the cavernous portion of ICA being the most common site.
Background
The number of people with diabetes mellitus (DM) in
2010 is estimated to be 285 million, which was approxi-
mately 7% of the adult world population [1]. Macrovascu-
lar disease, characterized by atherosclerotic changes in
large blood vessels, is the major cause of morbidity and
mortality (80%) in type 2 DM [2]; its major clinical effects
are seen in the coronary arteries (angina, myocardial
infarction), lower extremities (gangrene), and carotid
arteries (stroke). The overall relative risk of stroke is 1.5-
3 times greater in patients with DM [3]. Recurrent stroke
is also twice as frequent in patients with DM [4]. More
importantly, short- and long-term mortalities after stroke
are significantly greater in patients with DM [5]. This
underscores the need to develop practical approaches for
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detecting cerebrovascular disease (CeVD) at an early
stage before clinical complications occur.
Although digital subtraction angiography (DSA) is the
gold standard for assessing degree of stenosis [6], it can-
not precisely predict plaque composition. Furthermore,
DSA is an expensive technique and requires direct arter-
ial catheterization, which makes it unacceptable for some
patients [7]. Therefore, other noninvasive modalities such
as MR imaging (MRI), computed tomography (CT), and
duplex ultrasound are more frequently applied, wherein
each offers some potential for plaque analysis. To our
knowledge, the characteristics of carotid and cerebrovas-
cular plaques detected by the recently developed
dual-source CT angiography (DSCTA) in patients with
symptomatic type 2 DM have not been discussed system-
atically. The purpose of this study was to evaluate the
prevalence and morphology of carotid and cerebrovascu-
lar atherosclerotic plaques by DSCTA in a large cohort of
patients with symptomatic type 2 DM.
Methods
Study patients
Within a 14-month period from July 2009 to August
2010, we retrospectively analyzed 125 consecutive
patients with symptomatic type 2 DM who were clini-
cally suspected with stenosis of the carotid and intracra-
nial arteries. Inclusion criteria were patients with type 2
DM having neurologic symptoms. Symptoms were clas-
sified as follows: (1) transient symptoms, i.e., transient
ischemic attack or amaurosis fugax and (2) prior stroke,
i.e., any ischemic event with neurologic symptoms.
Exclusion criteria were as follows: history of allergy to
iodine-containing contrast medium, renal insufficiency
(creatinine, ≥120 μmol/L), pregnancy, and lack of
laboratory or clinical data. All patients underwent
DSCTA of the carotid and cerebrovascular arteries. The
following baseline demographics, laboratory findings,
and medical history were obtained: age, gender, serum
cholesterol level, serum HbA1c level, history of DM,
hypertension, daily smoking, and cerebral infarction
(CI). DM was diagnosed based on a random plasma glu-
cose level ≥11.1 mmol/L or a fasting plasma glucose
level ≥7.0 mmol/L. Hypertension was defined as treat-
ment with antihypertensive agents at the time of admis-
sion, systolic blood pressure ≥140 mm Hg, or diastolic
blood pressure ≥90 mm Hg. Subjects were classified as
smoking if they smoked at least a cigarette per day in
the year before the study. CI, including lacunar infarct
and territorial infarct, was confirmed by CT or MRI.
CT protocols
All examinations were performed with a DSCTA scanner
(SOMATOM Definition, Siemens Medical Solutions,
Forchheim, Germany) using a standardized enhanced
carotid and cerebrovascular artery imaging protocol. The
scanning parameters in the dual-source mode were as
follows: 330-ms gantry rotation time, tube A (140 kV, 55
mAs) and tube B (80 kV, 230 mAs) with a collimation of
2 × 64 × 0.6 mm and pitch 0.65. The delay before CT
acquisition after injection was determined using bolus
tracking software, and a circular region of interest (ROI)
for attenuation measurement was placed in the right
common carotid artery (CCA). As soon as the signal
intensity in ROI reached a threshold of 100 HU, data
acquisition was started. A nonionic contrast medium
(80-100 mL; iopamidol, 370 mg iodine/mL; Bracco Sine
Pharmaceutical Corp. Ltd., Shanghai, China) was admi-
nistered immediately followed by 40 mL of saline chaser
solution was administered through an 18-gauge intrave-
nous antecubital catheter at a flow rate of 6 mL/s with a
dual-head power injector (Stellant; Medrad, Indianola,
PA, USA). CT data was acquired in a caudocranial direc-
tion from the aortic arch to the mid-skull.
Image reconstruction was performed at another 3 D
image analysis workstation (Syngo-Imaging, Siemens,
Medical Solution System, Forchheim, Germany) with
the following parameters: a soft convolution kernel, slice
thickness of 0.75 mm, and increment of 0.4 mm. The
DSCTA reader was permitted to utilize any or all avail-
able postprocessing image reconstruction algorithms,
including maximal intensity projection, multiplanar
reformat, curved planar reformat, or volume rendered
technique and dual energy direct bone removal CTA
(DE-BR-CTA).
Imaging analysis
All images were evaluated by 2 experienced observers
unaware of the clinical history of the patients. In case of
disagreement, a joint reading was performed and a con-
sensus decision was reached.
In order to improve reproducibility of the results, the ana-
lysis was performed on a segmental basis. According to the
criteria of North American Symptomatic Carotid Endarter-
ectomy Trial (NASCET) [8], carotid and cerebrovascular
vessels were divided into 40 segments including CCA, caro-
tid bifurcation (CB), external carotid arteries, internal caro-
tid arteries (ICA) (C1-C7), extracranial vertebral artery
(eVA), intracranial vertebral artery (iVA), basilar artery
(BA), anterior cerebral artery (A1, A2), middle cerebral
artery (M1, M2), posterior cerebral artery (P1, P2), anterior
communicating artery (ACoA), and posterior communicat-
ing artery (PCoA). These segments were also divided into 3
categories, including extracranial arteries (CCA, CB, CA,
C1, and eVA), intracranial ICA (C2-C7), and intracranial
arteries (iVA, BA, A1, A2, M1, M2, P1, P2, ACoA, and
PCoA). Only segments with a diameter >1.5 mm (as mea-
sured on DSCTA) were included. Three types of plaques
(Figure 1 and 2) were determined using the following
He et al. Cardiovascular Diabetology 2010, 9:91
http://www.cardiab.com/content/9/1/91
Page 2 of 6
classification proposed by Ballotta et al. [9]: (1) noncalcified
plaques, i.e., plaques with a density <50 HU; (2) calcified
plaques, i.e., plaques with a mean attenuation of 130 HU or
greater; and (3) mixed plaques, i.e., plaques with a mean
attenuation of 50-129 HU. The grade of stenosis was rated
according to the NASCET criteria [8], and all carotid and
cerebrovascular arterial stenosis was scored from 0-4
according to the following scale: 0%, 1%-29%, 30%-69%,
70%-99%, and 100%. Plaques were classified as obstructive
or nonobstructive based on a 70% threshold of luminal nar-
rowing. Each vessel was analyzed on at least 2 imaging
planes, 1 parallel and 1 perpendicular to the course of the
vessel. Vessel diameters were measured perpendicular to
the vessel course. For each patient the number of diseased
segments, plaque type, and degree of stenosis were deter-
mined and recorded.
Statistical analysis
Continuous variables were expressed as the mean ±
standard deviation. Categorical variables were presented
as percentages. Comparisons between different types of
plaque, degree of stenosis, and plaque location were per-
formed by the nonparametric chi-square test. All statis-
tical analyses were performed using SPSS version 16.0




Carotid and cerebrovascular DSCTA was performed in
125 patients with symptomatic type 2 DM. A total of
4723 arterial segments were included in this analysis,
while 277 vascular segments were not evaluated because
of deficiency or diameter <1.5 mm. Baseline characteris-
tics of the 125 patients who were analyzed are summar-
ized in Table 1.
Plaque prevalence, composition, and distribution
DSCTA revealed 11 (8.8%) patients without CeVD and
114 (91.2%) patients with CeVD. A total of 658 seg-
ments with plaque were identified, of which 296 (45%)
were noncalcified, 107 (16%) were mixed, and 255 (39%)
were calcified (p < 0.001). Regarding plaque distribution,
noncalcified plaques were mainly located in the intracra-
nial arteries (81.8%), mixed plaques in the intracranial
arteries (25.2%) and intracranial ICA (56.1%), and calci-
fied plaques in the intracranial ICA (65.9%) and extra-
cranial arteries (28.2%) (for all, p < 0.001; Table 2). The
distribution of plaques was extensive; 67 (58.8%) had
1st-5th diseased segments, and 35 (30.7%) 6th-10th dis-
eased segments. The most common site of all detected
plaques in the patients was the cavernous portion of
ICA (131/658, 19.9%) followed by C5 (70/658, 10.6%)
and CB (68/658, 10.3%).
Figure 2 Diffuse plaques and stenoses of a 62-year-old woman
with 15 years diabetes. A, CPR shows diffuse hard plaques in right
common carotid artery (solid arrow) and mixed plaques in right
internal carotid artery proximal segment (open arrow), and both
resulted 25% stenoses. B, maximum intensity projection (MIP)
reflects overview of the diffuse plaques and stenoses.
Figure 1 CTA images of a 51-year-old man with 13 years
diabetes. A, a stenosis ≥70% in left common carotid artery
proximal segment is caused by a non-calcified plaque (solid arrow)
as evidenced using curved planar reformat (CPR). B, volume-
rendered reconstruction (VRT) displays overview of arteries and
stenosis (solid arrow).
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Arterial stenosis
Of the segments with plaques, mild, moderate, severe ste-
nosis, and occlusion were observed in 443 (67%), 155
(24%), 51 (8%), and 9 (1%) segments, respectively (p <
0.001). In general, 598 (91%) showed nonobstructive
CeVD and 60 (9%) showed obstructive CeVD (p < 0.001).
There were different grades of stenosis in different pla-
ques. Noncalcified plaques led to 233 (78.7%) mild, 52
(17.6%) moderate, 10 (3.4%) severe, and 1 (0.3%) occlu-
sion. Mixed plaques led to 69 (64.5%) mild, 29 (27.1%)
moderate, 7 (6.5%) severe, and 2 (1.9%) occlusions. Calci-
fied plaques resulted in 141 (55.3%) mild, 75 (29.4%)
moderate, 33 (12.9%) severe, and 6 (2.4%) occlusions
(Table 2). There was a trend that noncalcified plaque
resulted in a higher incidence of nonobstructive lumen
narrowing while calcified plaque resulted in a higher inci-
dence of obstructive lumen narrowing. In total, for non-
calcified, mixed, and calcified plaques, 96.3%, 91.6%, and
84.7% were nonobstructive (p < 0.001), respectively.
Discussion
Type 2 DM is a disease with both metabolic and vascular
components [10]. Patients with DM should always con-
trol their risk factors and recognize the signs and symp-
toms of potentially fatal complications as early as
possible. Plaque morphology directly correlates with the
risk of embolism and occlusion [11], thus detecting pla-
ques at an early stage is of great clinical importance. As a
noninvasive modality, multidetector CT angiography
(MDCTA) offers some potential for plaque analysis
[12,13]. DSCTA offers many advantages over conven-
tional MDCTA. First, DSCTA can differentiate materials
by analyzing their attenuation differences [14]. As a
result, bone and calcified plaque can be removed from
vessels with iodine contrast. Second, reduction in radia-
tion dose is an important characteristic of DSCTA.
Zhang et al. [15] reported that compared with conven-
tional bone-subtraction CTA, DE-BR-CTA showed a
60% reduction in radiation dose for dual-source CTA,
avoiding the additional preliminary unenhanced CT
acquisition. Third, DSCTA has faster scan acquisition
and higher spatial resolution, allowing DSCT acquisition
with minimal patient motion registration artifact and bet-
ter visualization of mixed and noncalcified plaques in
small vessels [14,16]. Furthermore, DSCTA has advanced
postprocessing methods, especially easy-to-use bone-
removal algorithms for direct visualization of complex
vasculature, and high quality DSA-like imaging [16].
In our study, the metabolic disorders in patients with
symptomatic DM predominantly included hypertension,
glucose metabolism abnormalities, and dyslipidemia. A
high incidence and wide distribution of plaques were
identified in the present study. The heavy plaque burden
in patients with DM was probably because there were
more cerebrovascular risk factors resulting from meta-
bolic disorders that have been described as the cause of
atherosclerosis of the carotid and cerebrovascular
arteries [17,18]. Guidelines for treatment of specific con-
ditions with respect to metabolic disorders are being
developed [19] and should be promoted by healthcare
educators and providers.
Regarding the composition of atherosclerotic plaques
in patients with type 2 DM, we found that there were
relatively more noncalcified and calcified plaques and
less mixed plaques, which was consistent with previous
studies [1,20]. These observations may suggest a more
Table 1 Characteristics of our study population
Characteristics data
Age (years) 66.36 ± 12.38 (38-92)
Duration of diabetes (years) 6.4 ± 5.8 (0.3-32)
Men 78 (62.4)
Smoking 43 (34.4)
Duration of smoking (years) 28.5 ± 13.1 (0.2-60)
Hypertension 85 (68)
Duration of hypertension (years) 11.1 ± 10.7 (0.3-50)
CI 81 (64.8)
Plaques 114 (91.2)
Triglyceride (mmol/L) 1.6 ± 0.8 (0.4-6.4)
Cholesterol (mmol/L) 4.3 ± 1.2 (2.1-10.9)
HDL-C (mmol/L) 1.2 ± 0.4 (0.3-2.5)
LDL-C (mmol/L) 2.5 ± 1.1 (0.2-7.8)
HbA1c (%) 8.1 ± 1.8 (5.9-11.9)
Insulin 20 (16.0)
Oral agent 89 (71.2)
Nephropathy 22 (17.6)
Retinopathy 72 (57.6)
Results are given as mean ±standard deviation (range) or n (percentage).
Normal range (Triglyceride: 0.29-1.83 mmol/L; Cholesterol: 2.8-5.7 mmol/L;
HDL-C: >0.9 mmol/L; LDL-C:<4.0 mmol/L; HbA1c: 4.5%-6.1%). CI =
cerebrovascular infarction; HDL-C = high density lipoprotein cholesterol; LDL-
C: low density lipoprotein cholesterol.
Table 2 Comparison of stenosis and location between
different plaques
Characteristics Noncalcified Mixed Calcified P
Type 296(45) 107(16) 255(39) < 0.001
Stenosis
Mild 233(78.7) 69(64.5) 141(55.3) < 0.001
Moderate 52(17.6) 29(27.1) 75(29.4) < 0.001
Severe 10(3.4) 7(6.5) 33(12.9) < 0.001
Occlusion 1(0.3) 2(1.9) 6(2.4) 0.097
Location
Extracranial artery 39(13.2) 20(18.7) 72(28.2) < 0.001
Intracranial ICA 15(5.0) 60(56.1) 168(65.9) < 0.001
Intracranial artery 242(81.8) 27(25.2) 15(5.9) < 0.001
Results are given as n (percentage).
ICA = internal carotid artery.
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rapid development of atherosclerosis in the presence of
DM, with faster progression from noncalcified lesions to
completely calcified lesions [20]. A faster progression of
atherosclerosis has also been suggested previously on
the basis of event rates in patients with DM undergoing
nuclear perfusion imaging [21]. Interestingly, a recent
study using MDCT demonstrated that a higher propor-
tion of mixed plaque was found in diabetics than in
nondiabetics [22]. However, the number of study sub-
jects was small and they were all asymptomatic for car-
diac symptoms. There is no clear explanation for this
difference. Despite many controversies, noncalcified pla-
ques have been suggested as potentially vulnerable to
trigger plaque rupture or embolism [23]. It is important
to evaluate the CeVD potential and treat the remediable
plaques in a timely manner.
The present study demonstrated that patients with
symptomatic type 2 DM showed a significantly higher
prevalence of nonobstructive lesions (91%), confirming
the findings of previous studies [1,24,25]. Using 64-slice
MDCT, Scholte et al. [1] showed that coronary plaques
of patients with type 2 DM were primarily nonobstruc-
tive (82%). Saely et al. reported a similar relationship
between DM and nonobstructive plaques by invasive cor-
onary angiography [24]. It has been suggested that plaque
rupture may occur frequently in nonobstructive plaques
[24]. This finding is of clinical importance since these
plaques may be vulnerable to rupture and may be related
to the high morbidity and mortality in patients with DM.
As was shown in this study, the noncalcified plaques
were primarily located in the intracranial arteries, mixed
plaques in the intracranial arteries and intracranial ICA
and calcified plaques in the intracranial ICA and extra-
cranial arteries. A similar distribution of calcified pla-
ques has been shown in another study using 16-slice
MDCT [26]. In our study, a higher incidence of noncal-
cified plaque detected in intracranial vessels could be
attributed to better visualization of noncalcified plaques
in small vessels by DSCTA. In addition, we found a rela-
tively high incidence of mixed plaque in the vessels
located next to the cranium, due to the high spatial
resolution of DSCTA with easy-to-use bone-removal
algorithms that provides a direct visualization of com-
plex vasculature [16].
In our study, the most common site of plaques was
the cavernous portion of ICA. Wojak et al. [27] con-
firmed this, reporting that intracranial atherosclerotic
stenosis typically occurred in the petrous cavernous
siphon segments of ICA. Furthermore, Masuoka et al.
[28] investigated the cause of development of atheroma-
tous plaque around the cavernous portion of ICA using
serial 3-mm sections of 32 intracranial ICA segments
obtained from 50 cadavers, and found that the external
elastic lamina disappeared in the cavernous portion of
ICA; intimal thickening of ICA frequently appeared in
the horizontal segment of the cavernous portion of ICA,
which was the most common site of stenosis. Change in
the elasticity of the arterial wall in the cavernous portion
was suggested to be an important factor in the process
of atherosclerosis in the intracranial ICA.
Outlining the significance of our study, the prevalence
and morphology of carotid and cerebrovascular athero-
sclerotic plaques in patients with symptomatic type 2
DM by DSCTA has been systematically reported for the
first time. The DSCT findings, which depended on a
large study sample with cutting-edge technology, accu-
rately reflects characteristics of plaque and stenosis in
patients with symptomatic type 2 DM, and can be used
to conduct a further treatment plan.
There were several limitations to this study. First, this
study is a single centre, retrospective study. A study
with a larger patient population from various centers is
warranted to confirm these data. Second, the visualiza-
tion of noncalcified plaques by DSCT is limited by pla-
que size; smaller plaques located predominantly in the
smaller arteries may therefore be difficult to identify
accurately with the current generation of CT scanners.
Conclusion
DSCTA detected a high prevalence of CeVD in patients
with symptomatic type 2 DM. A relatively high propor-
tion of plaques was noncalcified and calcified, primarily
leading to nonobstructive stenoses. The distributions of
plaques were different and extensive, with the most
common site being the cavernous segment of ICA.
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